Vera Lúcia Dantas Nunes Caldeira de Moura
AuthID: R-000-M8N
1
TITLE: Particle size by design: Standardizing measurements for complex topical drug product assessment Full Text
AUTHORS: Chiarentin, Lucas; Moura, Vera; Major, Fabio; Catita, Jose ; Miranda, Margarida; Vitorino, Carla;
PUBLISHED: 2025, SOURCE: COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, VOLUME: 705
AUTHORS: Chiarentin, Lucas; Moura, Vera; Major, Fabio; Catita, Jose ; Miranda, Margarida; Vitorino, Carla;
PUBLISHED: 2025, SOURCE: COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, VOLUME: 705
2
TITLE: Mucoadhesion and rheology characterization in topical semisolid formulations: An AQbD-driven case study Full Text
AUTHORS: Chiarentin, Lucas; Moura, Vera; Vitorino, Carla;
PUBLISHED: 2025, SOURCE: INTERNATIONAL JOURNAL OF PHARMACEUTICS, VOLUME: 673
AUTHORS: Chiarentin, Lucas; Moura, Vera; Vitorino, Carla;
PUBLISHED: 2025, SOURCE: INTERNATIONAL JOURNAL OF PHARMACEUTICS, VOLUME: 673
3
TITLE: AQbD Approach Applied to NIR in a Complex Topical Formulation: Bifonazole as Case Study Full Text
AUTHORS: Chiarentin, Lucas; Moura, Vera; Pais, Alberto A. C. C.; Vitorino, Carla;
PUBLISHED: 2025, SOURCE: PHARMACEUTICS, VOLUME: 17, ISSUE: 7
AUTHORS: Chiarentin, Lucas; Moura, Vera; Pais, Alberto A. C. C.; Vitorino, Carla;
PUBLISHED: 2025, SOURCE: PHARMACEUTICS, VOLUME: 17, ISSUE: 7
4
TITLE: Targeted liposomal doxorubicin/ceramides combinations: The importance to assess the nature of drug interaction beyond bulk tumor cells
AUTHORS: Cruz, Ana Filipa A.; Fonseca, Nuno A. B.; Malheiro, Ana Rita; Melo, Joana B.; Gaspar, Maria Manuela ; Fernandes, Rui; Moura, Vera; Simoes, Sergio; Moreira, Joao Nuno;
PUBLISHED: 2022, SOURCE: EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, VOLUME: 172
AUTHORS: Cruz, Ana Filipa A.; Fonseca, Nuno A. B.; Malheiro, Ana Rita; Melo, Joana B.; Gaspar, Maria Manuela ; Fernandes, Rui; Moura, Vera; Simoes, Sergio; Moreira, Joao Nuno;
PUBLISHED: 2022, SOURCE: EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, VOLUME: 172
5
TITLE: Modelling the impact of nucleolin expression level on the activity of F3 peptide-targeted pH-sensitive pegylated liposomes containing doxorubicin
AUTHORS: Lopes, R; Shi, K; Fonseca, NA; Gama, A; Ramalho, JS; Almeida, L; Moura, V; Simoes, S; Tidor, B; Moreira, JN;
PUBLISHED: 2021, SOURCE: DRUG DELIVERY AND TRANSLATIONAL RESEARCH, VOLUME: 12, ISSUE: 3
AUTHORS: Lopes, R; Shi, K; Fonseca, NA; Gama, A; Ramalho, JS; Almeida, L; Moura, V; Simoes, S; Tidor, B; Moreira, JN;
PUBLISHED: 2021, SOURCE: DRUG DELIVERY AND TRANSLATIONAL RESEARCH, VOLUME: 12, ISSUE: 3
6
TITLE: Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy
AUTHORS: Brignole, C; Bensa, V; Fonseca, NA; Del Zotto, G; Bruno, S; Cruz, AF; Malaguti, F; Carlini, B; Morandi, F; Calarco, E; Perri, P; Moura, V; Emionite, L; Cilli, M; De Leonardis, F; Tondo, A; Amoroso, L; Conte, M; Garaventa, A; Sementa, AR; ...More
PUBLISHED: 2021, SOURCE: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, VOLUME: 40, ISSUE: 1
AUTHORS: Brignole, C; Bensa, V; Fonseca, NA; Del Zotto, G; Bruno, S; Cruz, AF; Malaguti, F; Carlini, B; Morandi, F; Calarco, E; Perri, P; Moura, V; Emionite, L; Cilli, M; De Leonardis, F; Tondo, A; Amoroso, L; Conte, M; Garaventa, A; Sementa, AR; ...More
PUBLISHED: 2021, SOURCE: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, VOLUME: 40, ISSUE: 1
7
TITLE: The Enhanced Efficacy of Intracellular Delivery of Doxorubicin/C6-Ceramide Combination Mediated by the F3 Peptide/Nucleolin System Is Supported by the Downregulation of the PI3K/Akt Pathway Full Text
AUTHORS: Cruz, AF; Caleiras, MB; Fonseca, NA; Goncalves, N; Mendes, VM; Sampaio, SF; Moura, V; Melo, JB; Almeida, RD; Manadas, B ; Simoes, S; Moreira, JN;
PUBLISHED: 2021, SOURCE: CANCERS, VOLUME: 13, ISSUE: 12
AUTHORS: Cruz, AF; Caleiras, MB; Fonseca, NA; Goncalves, N; Mendes, VM; Sampaio, SF; Moura, V; Melo, JB; Almeida, RD; Manadas, B ; Simoes, S; Moreira, JN;
PUBLISHED: 2021, SOURCE: CANCERS, VOLUME: 13, ISSUE: 12
8
TITLE: Differential effect of liposomal C6-ceramide/doxorubicin targeted to nucleolin and conventional combinations against triple negative
AUTHORS: Ana F Cruz; Nuno A Fonseca; Nelio Goncalves; Vera Moura; Sergio Simoes; Joao Nuno Moreira;
PUBLISHED: 2019, SOURCE: Annual Meeting of the American-Association-for-Cancer-Research (AACR) in CANCER RESEARCH, VOLUME: 79, ISSUE: 13
AUTHORS: Ana F Cruz; Nuno A Fonseca; Nelio Goncalves; Vera Moura; Sergio Simoes; Joao Nuno Moreira;
PUBLISHED: 2019, SOURCE: Annual Meeting of the American-Association-for-Cancer-Research (AACR) in CANCER RESEARCH, VOLUME: 79, ISSUE: 13
INDEXED IN: 
WOS
WOS9
TITLE: Anticancer activity and antibody-dependent cell-mediated cytotoxicity of novel anti-nucleolin antibodies
AUTHORS: Romano, S; Moura, V; Simoes, S; Moreira, JN; Goncalves, J;
PUBLISHED: 2018, SOURCE: SCIENTIFIC REPORTS, VOLUME: 8, ISSUE: 1
AUTHORS: Romano, S; Moura, V; Simoes, S; Moreira, JN; Goncalves, J;
PUBLISHED: 2018, SOURCE: SCIENTIFIC REPORTS, VOLUME: 8, ISSUE: 1
10
TITLE: Moving liposome technology from the bench to the oncological patient: Towards performance-by-design
AUTHORS: Cruz, AF; Fonseca, NA; Gregório, AC; Moura, V; Simões, S; Moreira, JN;
PUBLISHED: 2018, SOURCE: AAPS Advances in the Pharmaceutical Sciences Series, VOLUME: 29
AUTHORS: Cruz, AF; Fonseca, NA; Gregório, AC; Moura, V; Simões, S; Moreira, JN;
PUBLISHED: 2018, SOURCE: AAPS Advances in the Pharmaceutical Sciences Series, VOLUME: 29
